Introduction
Establishment of TGFa/EGF and insulin-like growth factor-I (IGF-I) autocrine secretion and overexpression of EGF and IGF-I receptors are frequently identi®ed in carcinoma cells. In addition to roles in cell proliferation and transformation, IGF-I has frequently been documented as a survival factor. The antiapoptotic eect of IGF-I is not only important under condition of serum starvation, but also protects tumor cells from radiation-or chemotherapeutic drug-induced apoptosis (Dunn et al., 1997; Turner et al., 1997) . However, the role of EGF in the promotion of cell survival has only been reported in a limited number of cases. For example, EGF suppresses apoptosis induced by transforming growth factor b (TGFb) in primary hepatocytes (Fabregat et al., 1996) . In mammary epithelial cells, apoptosis induced by a combination of serum-free medium and high cell density is prevented by EGF (Merlo et al., 1995) . EGF also inhibits cell death induced by serum deprivation in PC12 cells (Yao and Cooper, 1995) .
The signal transduction pathways that prevent apoptosis are beginning to be elucidated. Phosphatidylinositol 3-kinase (PI3-K) and its downstream substrate Akt/PKB are identi®ed as the key molecules in antiapoptotic signals. For instance, activation of PI3-KAkt pathway is necessary for IGF-I or interleukin-3 (IL-3) to prevent apoptosis caused by UV or by growth factor withdrawal (Kulik et al., 1997; Minshall et al., 1996; Parrizas et al., 1997) . They are also necessary for platelet-derived growth factor (PDGF) or nerve growth factor (NGF) to prevent cell death induced by serum deprivation Yao and Cooper, 1996) . On the contrary, the involvement of extracellular signal-regulated kinases (ERKs), a subfamily of the mitogen-activated protein (MAP) kinases in the survival signals remains controversial. While the MAP kinase pathway seems to be necessary for the prevention of apoptosis by NGF or IGF-I in serumstarved PC12 cells (Parrizas et al., 1997; Xia et al., 1995) , the activation of the MAP kinase pathway is not essential for IGF-I to promote the survival of serumdeprived cerebellar neurons , hyperosmolarity shocked neuroblastoma cells (Singleton et al., 1996) , or UV-irradiated ®broblasts (Kulik et al., 1997) .
Apoptotic signals initiated by a variety of stimuli converge on activation of a family of cysteine proteases, namely caspases (Dragovich et al., 1998; Thornberry and Lazebnik, 1998) . Caspase activation results in proteolytic degradation of many proteins and ®nally causes apoptotic morphology. The Bcl-2 family genes provide additional controls of mammalian cell survival or apoptosis, which function as either positive or negative regulators of apoptosis (for review, see Adams and Cory, 1998) . Akt/PKB has been shown to inhibit apoptosis by phosphorylating the pro-apoptotic proteins Bad del Peso et al., 1997; Zha et al., 1996) and caspase-9 (Cardone et al., 1998) . Other than Akt/PKB, little is known about how survival signals link to apoptotic machinery.
We have previously demonstrated that human esophageal carcinoma (CE) cell lines overexpressed EGF receptor and IGF-I receptor and secreted TGFa, IGF-I and PDGF. Blocking of these autocrine loops under condition of serum deprivation caused a decrease of cell growth (Chen et al., 1991; Liu et al., 1996) . To study if EGF receptors may transduce survival signals in CE cells, we used staurosporineinduced apoptosis as a model to address this question. Staurosporine is a potent wide spectrum protein kinase inhibitor (Omura et al., 1995; Ruegg and Burgess, 1989) . It is reported to cause apoptosis in many cell types, such as CHO cells (Reynolds et al., 1996) , leukemia cells (Shao et al., 1997a; Wang et al., 1995) , and breast or colon carcinoma cell lines (Shao et al., 1997a; Shao et al., 1997b) . In this study, we found that EGF not only promotes the growth of CE81T/VGH cells but also protects them from staurosporine-induced apoptosis. Furthermore, the anti-apoptotic signal of EGF may be mediated by up-regulating mcl-1 through the Raf-MEK-ERK pathway. 
Results

Staurosporine induces apoptosis in CE81T/VGH cells
To examine whether the signals delivered from EGF receptors may play a role in regulating cell survival, we have chosen staurosporine-induced apoptosis of CE81T/VGH cells as a model system for this study. Figure 1a shows that CE81T/VGH cells contain intact nuclei under serum-free (SF) medium, whereas staurosporine (ST) induced micronucleation, which is a characteristic of apoptotic cells. More than 50% of the cells had fragmented nuclei after the treatment of 100 nM ST. The induction of apoptosis increased in a dose-dependent manner (Figure 1b , left) and reached the plateau at 48 h (Figure 1b, right) . Furthermore, the appearance of an 85-kDa fragment of poly(ADP)-ribose polymerase (PARP), another characteristic of apoptotic cells, was also observed after 24 h treatment of ST (Figure 1c ).
EGF protects CE81T/VGH cells from staurosporineinduced apoptosis
CE81T/VGH cells were shown to secrete TGFa and overexpress EGF receptors (Wong et al., 1992) . EGF promoted a twofold increase in cell number in CE81T/VGH cells (Figure 2a) . Besides the mitogenic eect, EGF also reduced the percentage of apoptotic cells from 48 ± 13% (Figure 2b) . At a concentration of 30 ng/ml, EGF gave the maximum of protective eect against ST-induced apoptosis (Figure 2c ). EGF also inhibited the cleavage of PARP as early as 12 h, and this eect lasted at least 30 h (Figure 2d ). The Raf-MEK-ERK pathway is involved in the anti-apoptotic effect of EGF To determine the possible signal pathway(s) that mediated the anti-apoptotic function of EGF, a speci®c MEK1/2 inhibitor PD98059 was used to block the activation of the MEK-ERK pathway upon EGF stimulation. The phosphorylation of a MEK substrate ERK2 was ®rst measured to reveal the ecacy of PD98059. As shown in Figure 3a , ERK2 was mainly unphosphorylated and detected as a faster migrating band when cells were cultured under SF conditions or treated with ST. Administration of EGF resulted in the phosphorylation of over 90% of ERK2 (P-ERK2). The level of phosphorylated ERK2 was reduced 30% and 40% after the addition of 10 mM and 25 mM PD98059, respectively. This result indicated that PK98059 substantially suppressed the activation of MEK-ERK pathway by EGF. Since the PI3-K-Akt pathway has been implicated in the prevention of apoptosis in response to growth factors and cytokines, we used wortmannin to test the possible involvement of PI3-K in the protective eect of EGF. In vitro PI3-K assays demonstrated that EGF stimulated the production of phosphatidylinositol-3-phosphate (PI-3P) ( Figure 3b ). In the presence of 1 mM wortmannin, the activation of PI3-K induced by EGF was reduced 64%, indicating that wortmannin was eective in suppressing PI3-K activity in CE81T/VGH cells.
The eects of PD98059 and wortmannin on the antiapoptotic function of EGF were examined. As shown in Figure 3c , PD98059 signi®cantly reversed the protective eect of EGF on apoptosis in a dosedependent manner. Compared to cells treated with ST plus EGF, the addition of 25 mM PD98059 resulted in twofold increase in apoptotic cells ( Figure 3c , ST+EGF and ST+EGF+P25). The enhancement of apoptosis was not attributed to cytotoxicity of PK98059 because the inhibitor itself did not cause apoptosis (Figure 3c, P25) . This result suggests that EGF prevents apoptosis via the MEK-ERK pathway. Interestingly, wortmannin had little eect on the antiapoptotic eect of EGF even when the concentration was raised to 5 mM (Figure 3d , compare ST+EGF and ST+EGF+W5). These data suggest that the antiapoptotic function of EGF is mediated through the MAP kinase but not the PI3-K pathway. Figure 3 The MAP kinase pathway is involved in the antiapoptotic eect of EGF. (a) PD98059 suppresses the phosphorylation of ERK2 induced by EGF. Cells were cultured under SF conditions as described in Figure 1 . Before the addition of ST and EGF, cells were treated with PD98059 (P, 10 mM or 25 mM) for 2 h. SF medium containing ST, EGF and PD98059 (P10 or P25) was then added. Cell lysates were prepared after 15 min and 50 mg total protein per lane was subjected to SDS ± PAGE followed by Western blotting. Speci®c anti-ERK2 antibody, which recognizes ERK2 but not ERK1, was used as the primary antibody. The slower migrated band is phosphorylated, active form of ERK2 (P-ERK2). (b) Wortmannin inhibits the activation of PI3-K induced by EGF. Before the addition of ST and EGF, cells were treated with wortmannin (W, 0.01, 0.1, or 1 mM) for 4 h. SF medium containing ST, EGF, and wortmannin (W0.01, W0.1, or W1) was then added for 5 min. Cells were lysed and immunoprecipitated with anti-phosphotyrosine antibody. 20 mg phosphatidylinositol (PI) was added to the immunoprecipitates and the kinase reaction was initiated by the addition of g-32 P-ATP. The phosphorylated PI (PI-3P) was analysed by the thin layer chromatography and visualized by autoradiography. (c) PD98059 reverses the protective eect of EGF. Cells were cultured and pretreated with PD98059 as described in (a). Forty-eight h after the addition of ST, EGF, and PD98059, the percentages of apoptotic cells were counted. (d) Wortmannin fails to block the protective eect of EGF. Cells were cultured and pretreated with wortmannin as described in (b). Forty-eight h after the addition of ST, EGF, and wortmannin, the percentages of apoptotic cells were counted To con®rm this ®nding, we co-transfect the plasmid pCMV5Erk2 (Y185F), an ERK2 dominant negative (DN) mutant (Figure 4d , ERK2(YF)) (Frost et al., 1994) and the plasmid pCMV-b, a b-galactosidase expression vector into CE81T/VGH cells and then treated the cells with staurosporine and EGF. The transfected cells were identi®ed by staining for b-galactosidase in the cytoplasm and the fragmentation of chromosomes in the nucleus was revealed by staining with Hoechst 33258. The percentage of apoptotic cells among total transfected cells was calculated as described in Materials and methods. Figure 4a shows a non-apoptotic, transfected (b-galactosidase positive) cell, while two apoptotic, transfected cells are shown in Figure 4b and c. Figure  4d shows that transfection of the ERK2 DN mutant substantially reduced the protective eect of EGF; the percentage of apoptotic cells was increased from 11% to 23% (compare ST+EGF treatments of ERK2 and ERK2(YF)). Furthermore, transfection of v-raf that constitutively activates the MEK-ERK pathway protected cells from apoptosis in the absence of EGF ( Figure  4e ). Taken together, these data suggest that the Raf-MEK-ERK pathway is involved in the anti-apoptotic function of EGF, and activation of this pathway is sucient to block staurosporine-induced apoptosis in CE81T/VGH cells. For convenience, we will use`the MAP kinase pathway' instead of`the Raf-MEK-ERK pathway' in the text here.
EGF up-regulates the expression of an anti-apoptotic protein Mcl-1
To examine the role of Bcl-2 gene family members in the anti-apoptotic eect of EGF, we examined the protein levels of Bcl-2 gene family members in CE81T/VGH cells under various treatments. Figure 5a shows that little (Figure 5b) . Administration of 100 ng/ml EGF in the presence of ST also up-regulated Mcl-1 to the level which is equivalent to that induced by EGF alone (Figure 5b) . Similar results were also observed after 24 h treatment (data not shown). To determine at which level EGF regulates mcl-1 expression, we did Northern blot analysis at dierent time intervals. EGF treatment increased the steady-state mRNA level of mcl-1. Both the 3.8-kb and 2.5-kb transcripts of mcl-1 were induced by EGF within 1 h (Figure 5c ). The induction reached a peak at 1.5 h, and then dropped after 2 h. The induction of mcl-1 transcripts by EGF was also observed in the presence of ST (Figure 5d ).
EGF up-regulates Mcl-1 via the MAP kinase pathway
Since both the activation of the MAP kinase pathway and the induction of Mcl-1 were observed in the EGF- (Figure 6c) . Thus, the induction of Mcl-1 by EGF is not mediated via the PI3-K pathway.
Transfection of mcl-1 inhibits staurosporine-induced apoptosis
To test if the up-regulation of Mcl-1 could prevent CE81T/VGH cells from staurosporine-induced apoptosis, we transiently transfected the plasmid pcDNA3-HA-h-mcl-1 which expressed human mcl-1 under the control of cytomegaloviral (CMV) early promoter and the plasmid pCMV-b into CE81T/VGH cells. 
Discussion
EGF has been generally recognized as a mitogenic factor that stimulates the growth of ®broblasts and epithelial cells. We have previously demonstrated that human esophageal carcinoma cells constitutively secrete TGFa and overexpress EGF receptors and that EGF can promote cell growth (Chen et al., 1991) . In this study, we further demonstrated that EGF can prevent staurosporine-induced apoptosis in human esophageal carcinoma cells. The MAP kinase and the PI3-K/Akt(PKB) pathways are among two of the most studied pathways involved in survival signals. We have provided three lines of evidences which suggest that EGF modulates the survival of CE81T/VGH cells through the activation of the Raf-MEK-ERK pathway. The speci®c MEK inhibitor PD98059 (Alessi et al., 1995; Pang et al., 1995) suppressed the anti-apoptotic eect of EGF on staurosporine-treated cells (Figure 3b) , implying the involvement of MEK-ERK pathway. In addition, transiently transfected ERK2 DN mutant suppressed the protective eect of EGF (Figure 4d) . Furthermore, the expression of v-raf in CE81T/VGH cells prevented staurosporine-induced apoptosis (Figure 4e) . Thus, our data indicate that MAP kinase pathway may transduce a major survival signal of EGF. On the contrary, a PI3-K inhibitor, wortmannin, failed to aect the protective eect of EGF (Figure 3c) . Thus, PI3-K seems not to be involved in the anti-apoptotic eect of EGF. Similar to our ®ndings, the importance of MEK-ERK pathway has been illustrated in the anti-apoptotic signals of NGF and IGF-I in PC12 cells (Parrizas et al., 1997; Xia et al., 1995) . Although the PI3-K pathway has been reported to be involved in the survival of many cell types, CD28 mediated T cell survival (Collette et al., 1997) and IL-3 mediated myeloid progenitor cell survival (Minshall et al., 1996; Zamorano et al., 1996) are not aected by wortmannin. In addition, in IGF-I receptor overexpressing Rat-1 cells, the survival signal of IGF-I is no longer dependent on PI3-K or Akt (Kulik and Weber, 1998) . These observations may be due to the dierences in cellular content, survival factors, or the stimuli inducing apoptosis. The other possibility is that more than one survival pathway exists in cells and the blockade of only one pathway does not aect cell survival.
Another interesting ®nding in this study is that the MAP kinase pathway participates in EGF-induced Mcl-1 expression. Mcl-1 shares sequence homology with Bcl-2 and was reported to delay or inhibit apoptosis induced by c-Myc (Reynolds et al., 1994) or staurosporine (Reynolds et al., 1996) in CHO cells, although its ecacy was not as good as Bcl-2 or Bcl-x L . We found that overexpression of Mcl-1 protected CE81T/VGH cells from staurosporine-induced apoptosis and transfection of a Mcl-1 antisense plasmid substantially increased the percentage of apoptotic cells (Figure 7 ). Our data support the fact that Mcl-1 is an inducible, antiapoptotic protein, as previously described in myeloid cells induced by TPA and GM-CSF (Kozopas et al., 1993; Chao et al., 1998) , and in EBV immortalized B cells induced by IL-6 (Altmeyer et al., 1997) . While the induction of Mcl-1 by TPA was mediated through the MAP kinase pathway in myeloblastic leukemia cells (Townsend et al., 1998) , the IL-3 activation of mcl-1 gene expression was mediated via PI3-K-Akt-dependent andindependent pathways in murine pro-B Ba/F3 cells (Wang et al., 1999) . Thus, there seems to be more than one pathway involved in the induction of Mcl-1. We clearly demonstrate in this study that the MAP kinase pathway is involved in the EGF-induced Mcl-1 expression, although the contribution of other mechanisms cannot be ruled out in CE81T/VGH cells.
By what mechanism does Mcl-1 regulate apoptosis? In the yeast two-hybrid system, Bcl-2, Bcl-x L , and Mcl-1 could bind to Bax (Sato et al., 1994) . In addition, the Bcl-2/Bax and Bcl-x L /Bax heterodimers were detected in mammalian cells. Yang and Korsmeyer (1996) proposed that the ratio of Bcl-2 (or Bcl-x L ) to Bax determined the amount of Bcl-/Bax heterodimers versus Bax/Bax homodimers within a cell and also the fate of a cell. Based on this model, Mcl-1 may associate with Bax to form heterodimers, allowing more Bcl-2/Bcl-2 but not Bcl-2/Bax formation, thus preventing apoptosis. However, we were unable to detect the presence of Mcl-1/Bax heterodimer in CE81T/VGH cells by co-immunoprecipitation (data not shown). On the other hand, Mcl-1 may regulate apoptosis by forming channels in cellular membranes like other Bcl-2 gene family members (Antonsson et al., 1997; Minn et al., 1997; Schendel et al., 1997) since Mcl-1 is also distributed to mitochondria (Yang et al., 1995) . Whether Mcl-1 forms ion channels in the intracellular membrane and regulates the homeostasis of mitochondria need further investigation. However, EGF was indeed able to prevent the cleavage of PARP induced by staurosporine, suggesting that the induction of Mcl-1 may inhibit the activation of caspase(s).
In the past, EGF has rarely been considered as a survival factor. In this study, we found that the optimal concentration of EGF for a maximal eect on cell survival was dierent from that on cell proliferation (Figure 2a,c) . The mitogenic activity of EGF reached a peak at 5 ng/ml (8610 710 M) and declined at higher concentrations. However, the antiapoptotic eect reached a plateau at 30 ng/ml (5610 79 M). In EGF receptor-overexpressing Rat-1 cells (Osterop et al., 1994) and a human breast epithelial cell line MCF-10A (Basolo et al., 1992) , a signi®cantly higher mitogenic eect was seen after the addition of 10 710 M rather than 10 79 M EGF. Thus, EGF may utilize high anity or low anity receptors to transduce mitogenic or survival signals, respectively. Another explanation is that dierent concentrations of EGF may trigger the dimerization of dierent ErbB family receptors and result in dierent downstream signals. In our system, CE81T/VGH is an esophageal carcinoma cell line which growth is dependent on TGFa/EGF receptor autocrine stimulation under serum-free conditions (Liu et al., personal communication) . Furthermore, the EGF receptors are ampli®ed and overexpressed in CE81T/VGH cells (Wong et al., 1992) . Thus, we speculate that the anti-apoptotic eect of EGF may be stronger or easier to demonstrate in EGF receptor overexpressed cells. This idea may be strengthened by other groups' observations. For example, Kulik et al., (1997) and Pierce et al., (1988) also found that EGF prevented apoptosis only in EGF receptor-overexpressing Rat-1 ®broblasts or 32D hematopietic cells. In addition, the numbers of EGF receptor were more than 10 5 per cell in those cells which EGF has been reported as a survival factor (Merlo et al., 1995; Yao and Cooper, 1995) . On the contrary, EGF failed to protect against drug-induced apoptosis in MCF-7 (Geier et al., 1995) , a breast carcinoma cell line containing only 800 EGF receptors per cell (Fitzpatrick et al., 1984) .
During tumor progression, loss of the ability to undergo apoptosis seems to be a critical step for tumor cells to survive under deprivation of growth factors. Autocrine survival factors may also protect the tumor cells from chemotherapeutic drugs. Secretion of TGF a/EGF and overexpression of EGF receptors were not only reported in human esophageal carcinoma cell lines, but were also detected in human esophageal carcinoma tissues (Lu et al., 1988; Ozawa et al., 1987 Ozawa et al., , 1989 . In fact, the prognosis is poorer in esophageal cancer patients whose tumors express a higher level of EGF receptors (Iihara et al., 1993; Ozawa et al., 1989) . Thus, the mitogenic and anti-apoptotic signals transduced from EGF receptors may play a very important role in the growth and prognosis of human esophageal carcinomas.
Materials and methods
Cell line and plasmids
The human esophageal carcinoma cell line CE81T/VGH was established in our laboratory (Hu et al., 1984) and routinely cultured in Dulbecco's modi®ed Eagle's medium (DMEM) with 5% fetal calf serum (FCS). Plasmid pCMV-b is a mammalian expression vector which expresses bacterial bgalactosidase. The human Mcl-1 expression vector, pcDNA3-HA-h-mcl-1 (Chao et al., 1998) was kindly provided by Dr Hsin-Fang Yang-Yen (Academia Sinica, Taipei, Taiwan, ROC). The Mcl-1 antisense plasmid pcDNA3-h-mcl-1AS was constructed by excising pcDNA3-HA-h-mcl-1 with HindIII and XbaI, ®lling the protruding end of the fragments by T4 polymerase, and ligating the 1.1-kb human mcl-1 cDNA with the vector. The plasmid which expresses mcl-1 antisense transcript was picked and checked by both restriction enzyme digestions and sequencing. Plasmid 3611-MSV that contains MSV LTR driven v-raf (Rapp et al., 1983) 
Antibodies and other reagents
Rabbit anti-poly (ADP-ribose) polymerase (PARP) antibody and anti-phosphotyrosine monoclonal antibody (4G10) were purchased from Upstate Biotechnology (Lake Placid, NY, USA). Antibodies against human Mcl-1, Bax, Bcl-x L , and ERK2 were from Santa Cruz (Santa Cruz, CA, USA). AntiBcl-2 and anti-b-galactosidase were from Boehringer Mannheim (Mannheim, Germany). Staurosporine, wortmannin, and Hoechst 33258 were from Sigma (St Louis, MO, USA). PD98059 was from Calbiochem (La Jolla, CA, USA). EGF was purchased from Intergen (Purchase, NY, USA).
Western and Northern blotting
Cells were washed twice with Hank's balanced salt solution (HBSS), and lysed either in NET buer (50 mM Tris, pH 7.4, 1 mM EDTA, 150 mM NaCl, and 0.5% NP-40) for protein extraction, or in ZolB (Biotecx Laboratories, Houston, TX, USA) for RNA extraction. 50 mg protein per lane was subjected to 12.5% SDS ± PAGE and Western blotting. 30 microgram RNA was applied per lane for Northern blotting. A 1.1-kb BamHI ± XhoI fragment from pcDNA3-HA-h-mcl-1 was used as a probe to detect mcl-1 transcript.
Apoptosis assay
A DNA binding dye Hoechst 33258 was used to detect micronucleation in apoptotic cells. In brief, 5610 4 cells were seeded into 24-well plates in 5% FCS-containing DMEM. After incubation overnight, cells were washed once with HBSS, and then maintained in the serum-free medium for 1 day. Staurosporine and growth factors diluted in fresh serumfree medium to the desired concentrations were added into the culture. Both¯oating and adherent cells were collected after 48 h. The cells were ®xed in 2% formaldehyde, treated with acetone for 10 min, and then stained with 0.5 mg/ml Hoechst 33258 for 10 min. The morphology of nuclei was observed under¯uorescence microscope and apoptotic cells were scored. At least 200 cells were counted for each of the duplicate experiments.
Transient transfection and double staining
For the transfection experiments, 10 mg of pCMV-b and 10 mg of other plasmids as speci®ed (except pcDNA3-h-mcl-1AS) were transiently co-transfected into 4610 6 CE81T/ VGH cells by electroporation. In the Mcl-1 antisense experiment, 18 mg of pcDNA3-h-mcl-1AS and 2 mg of pCMV-b were used. After electroporation, 1610 6 cells were seeded into each well of 24-well plates. Two days later, cells were washed once with HBSS and cultured in DMEM containing 0.1% FCS for another 24 h. The cells were then treated with 30 nM staurosporine with or without 30 ng/ml EGF in 0.1% FCS DMEM for 2 days, harvested and ®xed as described in the apoptosis assay. The transfected cells were identi®ed by the staining of the cells with anti-b-galactosidase monoclonal antibody and Texas-red conjugated goat antimouse antibody. The DNA in the nuclei was then stained with 1 mg/ml Hoechst 33258. Nuclear morphology (bluē uorescence) in the transfected cells (red¯uorescence in the cytoplasm) was observed under¯uorescence microscope and the percentages of apoptotic cells were counted.
Phosphatidylinositol 3-kinase assay PI3-K assay was performed as described previously (Sato et al., 1993) . In brief, 2.5610 6 cells were lysed in 0.5 ml lysis buer (20 mM Tris, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1% NP-40, 10% glycerol, 1 mg/ ml bovine serum albumin, 1 mM phenylmethylsulfonyl uoride, 2 mg/ml aprotinin, and 2 mM sodium vanadate). The cell lysate was pre-incubated with 30 ml protein ASepharose at 48C for 1 h and the protein A-Sepharose was discarded after centrifugation. The supernatant was immunoprecipitated with 1 mg anti-phosphotyrosine antibody 4G10 and 30 ml protein A-Sepharose at 48C overnight. The immune complex beads were washed three times with lysis buer, twice with LiCl buer (100 mM Tris, pH 7.6, 0.5 M LiCl), and twice with TNE buer (10 mM Tris, pH 7.6, 100 mM NaCl, 1 mM EDTA). 10 ml phosphatidylinositol (Sigma, 2 mg/ml in 20 mM HEPES, pH 7.4) was pre-incubated with the immune complex beads on ice for 10 min. Kinase reaction was initiated by the addition of 40 ml reaction buer (20 mM HEPES, pH 7.4, 10 mCi [g-32 P]ATP, 20 mM ATP, 5 mM MgCl 2 ) at room temperature for 15 min. The reaction was stopped by the addition of 100 ml 1 N HCl, and 200 ml of chloroform/methanol (1 : 1) was added to extract lipid. Lipid in the organic phase was spotted onto a thin-layer chromotography plate and developed in chloroform/methanol/4M NH 4 OH (9 : 7 : 2). Labeled phosphatidylinositol 3-phosphate (PI3-P) was visualized by autoradiography.
